Alloy Therapeutics: $40 Million Series E At $1 Billion Valuation Raised To Scale AI-Driven Biotech Infrastructure
By Amit Chowdhry ● Yesterday at 3:00 PM
Alloy Therapeutics announced it has raised $40 million in a Series E round, reaching a $1 billion valuation as it expands its AI-powered platform for drug discovery and development. The round included new investors such as 8VC, JIC Venture Growth Investments, and Echo Capital, alongside existing backers including Mubadala Capital, Presight Capital, Thiel Capital, Founders Fund, Alexandria Venture Investments, Gaingels, and Ulysses Diversified Holdings.